Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.91
+0.17 (1.95%)
At close: Sep 26, 2025, 4:00 PM EDT
8.89
-0.02 (-0.22%)
After-hours: Sep 26, 2025, 7:00 PM EDT

Emergent BioSolutions Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
4755181255892,3394,749
Upgrade
Market Cap Growth
18.69%315.99%-78.86%-74.81%-50.75%70.50%
Upgrade
Enterprise Value
8841,0449171,4142,8245,255
Upgrade
Last Close Price
8.919.562.4011.8143.4789.60
Upgrade
PE Ratio
3.53---10.6515.53
Upgrade
Forward PE
4.11--51.157.199.53
Upgrade
PS Ratio
0.560.500.120.531.323.01
Upgrade
PB Ratio
0.891.070.190.431.453.28
Upgrade
P/TBV Ratio
7.07-1.511.342.999.18
Upgrade
P/FCF Ratio
3.0714.47--24.3412.02
Upgrade
P/OCF Ratio
2.818.82--7.308.85
Upgrade
PEG Ratio
---11.760.210.68
Upgrade
EV/Sales Ratio
1.041.000.871.261.593.33
Upgrade
EV/EBITDA Ratio
4.0819.55-90.085.608.63
Upgrade
EV/EBIT Ratio
7.49---7.3210.53
Upgrade
EV/FCF Ratio
5.7029.17--29.3913.30
Upgrade
Debt / Equity Ratio
1.261.401.351.030.540.64
Upgrade
Debt / EBITDA Ratio
3.1212.66-90.851.721.50
Upgrade
Debt / FCF Ratio
4.3618.89--9.132.34
Upgrade
Asset Turnover
0.580.650.420.370.610.61
Upgrade
Inventory Turnover
1.132.092.031.853.012.70
Upgrade
Quick Ratio
2.731.560.470.662.292.22
Upgrade
Current Ratio
5.663.691.040.993.403.11
Upgrade
Return on Equity (ROE)
30.24%-33.67%-74.67%-14.11%14.35%24.12%
Upgrade
Return on Assets (ROA)
5.03%-2.03%-4.21%-2.23%8.26%11.98%
Upgrade
Return on Capital (ROIC)
5.96%-2.43%-4.84%-2.58%9.93%14.52%
Upgrade
Return on Capital Employed (ROCE)
9.10%---14.90%20.00%
Upgrade
Earnings Yield
29.35%-36.80%-610.73%-35.91%9.39%6.44%
Upgrade
FCF Yield
32.61%6.91%-207.11%-25.44%4.11%8.32%
Upgrade
Buyback Yield / Dilution
-5.75%-3.52%-2.20%7.39%-0.56%-2.67%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q